The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
26970660 |
3 |
Development of a potent 2-oxoamide inhibitor of secreted phospholipase A2 guided by molecular docking calculations and molecular dynamics simulations. |
National and Kapodistrian University of Athens |
21216150 |
16 |
Inhibition of secreted phospholipases A2 by 2-oxoamides based ona-amino acids: Synthesis, in vitro evaluation and molecular docking calculations. |
University of Athens |
18818074 |
81 |
Simplified YM-26734 inhibitors of secreted phospholipase A2 group IIA. |
University of Washington |
18605714 |
205 |
Highly specific and broadly potent inhibitors of mammalian secreted phospholipases A2. |
University of Washington |
17335183 |
78 |
Inhibition of secreted phospholipase A2. 4-glycerol derivatives of 4,5-dihydro-3-(4-tetradecyloxybenzyl)-1,2,4-4H-oxadiazol-5-one with broad activities. |
Université |
17154507 |
9 |
In silico-guided target identification of a scaffold-focused library: 1,3,5-triazepan-2,6-diones as novel phospholipase A2 inhibitors. |
Cnrs Umr 7175 |
16686528 |
40 |
The first potent inhibitor of mammalian group X secreted phospholipase A2: elucidation of sites for enhanced binding. |
University of Washington |
30300845 |
43 |
1-(2-Hydroxybenzoyl)-thiosemicarbazides are promising antimicrobial agents targeting d-alanine-d-alanine ligase in bacterio. |
Universit£ |
30034586 |
90 |
Design of Selective sPLA |
Astrazeneca |
30034585 |
49 |
Discovery of a Series of Indole-2 Carboxamides as Selective Secreted Phospholipase A |
Astrazeneca |